Navigation Links
The Conference Forum confirms agenda for the 4th annual Mobile in Clinical Trials event on September 6, 2017
Date:8/14/2017

The Conference Forum has confirmed the one-day agenda for the Mobile in Clinical Trials event, which will take place on September 6, 2017 at the Marriott Copley Place in Boston, MA.

Returning as program chair is Daniel Karlin, MD, Head of Experimental Medicine, Informatics, and Regulatory Strategy, Pfizer Innovative Research Lab, Pfizer, who leads 19 industry speakers in discussing how and when to implement mobile/digital technology in clinical trials and the potential benefits to be gained.

“Now in its fourth year, the Mobile program brings together speakers from key contributors to the development of digital technology in clinical trials,” says Conference Producer, Jennifer Moran. “Scheduled immediately before the 7th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference at the same venue, this full-day event provides an ideal opportunity to discover more about the value of using digital tools in drug development.”

The event starts with opening remarks by chair Dan Karlin. The morning includes sessions on: how to overcome the cultural barriers to implementing mobile technology; CTTI’s findings on their mobile clinical trials program and recommendations on novel endpoints; case study learnings from Medidata; FDA guidance on implementing digital/mobile strategies and tools in clinical research; GSK’s PARADE study; Roche’s Parkinson’s disease study; and new technologies in live five-minute demonstrations.

The afternoon sessions cover: how to introduce digital tools in a clinical trial from start to finish; demonstrating value-added to a Phase IV trial by introducing a valid wearable; the current realities of the virtual trial model; Verily’s study watch tackling the scalability of wearables in clinical trials; the why, what, where and how of the digital coach in clinical trials; and a call to action and reflection on the the day’s learnings.

Find out more about Mobile in Clinical Trials.

About the Conference Forum
The Conference Forum is a research firm that develops specialized events for professionals in the life science and healthcare industries. The company currently offers conferences for R&D leaders, clinical development professionals, biotech executives, VCs, drug delivery specialists, patient advocates and non-profit/government healthcare groups. The Conference Forum’s mission is to create the best content, facilitate the exchange ideas and provide quality networking to help move therapeutics to patients faster.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14599593.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Senomyx To Webcast Corporate Presentation At The 25th Annual ROTH Conference
2. Annual Conference about Technology Solutions for People with Disabilities Announces Program
3. Washington State University to Present on Tin Nanoneedles: A Technology for Lithium-ion Batteries, at Knowledge Foundation’s Next Generation Batteries 2013 Conference
4. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
5. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
6. Palatin Technologies To Present At The 25th Annual ROTH Conference
7. 3D Biomatrix Announces Stipend to Present at Spring 2013 Conferences
8. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
9. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
10. Life Sciences Technology Conference and Career Fair on March 26th in Raleigh, NC
11. Neogen Corporation Announces 3rd Quarter Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the second time ... US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. ... US2020. , US2020’s mission is to change the trajectory of STEM education in ...
(Date:10/10/2017)... CRUZ, Calif. , Oct. 10, 2017 ... grant from the NIH to develop RealSeq®-SC (Single Cell), ... kit for profiling small RNAs (including microRNAs) from single ... Analysis Program highlights the need to accelerate development of ... "New techniques for measuring ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
Breaking Biology News(10 mins):